Trial of ketotifen in childhood asthma.
An open trial of Ketotifen was conducted on 29 children suffering from asthma of varying duration. The drug was given orally in a dose of 1 mg twice a day. Children were followed up weekly for a period of 3 months. It was found beneficial (though the benefit was not statistically significant) in children having asthma of less than 2 years duration who were taking one drug regularly or were on occasional treatment. There was marginal effect in children taking salbutamol and theophylline together, but irregularly and no benefit in children taking prednisolone.
Pherwani
A V
AV
Institute of Child Health, J. J. Group of Government Hospitals, Bombay.
Desai
A G
AG
D000420:Albuterol / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007665:Ketotifen / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D013806:Theophylline / Q000008:administration & dosage
D011239:Prednisolone; D013806:Theophylline; D000420:Albuterol; D007665:Ketotifen